{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T15:46:27Z","timestamp":1794498387255,"version":"4.9.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1038\/s41401-020-0368-8","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T21:36:03Z","timestamp":1586295363000},"page":"1568-1575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Metrnl deficiency decreases blood HDL cholesterol and increases blood triglyceride"],"prefix":"10.1038","volume":"41","author":[{"given":"Qi","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-jun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-li","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai-long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-ying","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-yu","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"key":"368_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0828-282X(09)70715-9","volume":"25","author":"J Genest","year":"2009","unstructured":"Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, et al. 2009 Canadian Cardiovascular Society\/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol. 2009;25:567\u201379.","journal-title":"Can J Cardiol"},{"key":"368_CR2","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1210\/jcem.86.3.7304","volume":"86","author":"IJ Goldberg","year":"2001","unstructured":"Goldberg IJ. Clinical review 124: Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab. 2001;86:965\u201371.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"368_CR3","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.3233\/JAD-2011-110599","volume":"30","author":"C Reitz","year":"2012","unstructured":"Reitz C. Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations. J Alzheimers Dis 2012;30(Suppl 2):S127\u201345.","journal-title":"J Alzheimers Dis"},{"key":"368_CR4","first-page":"3900","volume":"21","author":"Z Chen","year":"2017","unstructured":"Chen Z, Zhao GH, Zhang YK, Shen GS, Xu YJ, Xu NW. Research on the correlation of diabetes mellitus complicated with osteoporosis with lipid metabolism, adipokines and inflammatory factors and its regression analysis. Eur Rev Med Pharmacol Sci. 2017;21:3900\u20135.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"368_CR5","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/j.dsx.2015.09.015","volume":"10","author":"M Rahimlou","year":"2016","unstructured":"Rahimlou M, Mirzaei K, Keshavarz SA, Hossein-Nezhad A. Association of circulating adipokines with metabolic dyslipidemia in obese versus non-obese individuals. Diabetes Metab Syndr. 2016;10:S60\u20135.","journal-title":"Diabetes Metab Syndr"},{"key":"368_CR6","doi-asserted-by":"publisher","first-page":"3021785","DOI":"10.1155\/2019\/3021785","volume":"2019","author":"S Coimbra","year":"2019","unstructured":"Coimbra S, Reis F. The protective role of adiponectin for lipoproteins in end-stage renal disease patients: relationship with diabetes and body mass index. Oxid Med Cell Longev. 2019;2019:3021785.","journal-title":"Oxid Med Cell Longev"},{"key":"368_CR7","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/aps.2018.40","volume":"39","author":"N Katsiki","year":"2018","unstructured":"Katsiki N, Mikhailidis DP, Banach M. Leptin, cardiovascular diseases and type 2 diabetes mellitus. Acta Pharmacol Sin. 2018;39:1176\u201388.","journal-title":"Acta Pharmacol Sin"},{"key":"368_CR8","first-page":"1296","volume":"21","author":"SS Habib","year":"2017","unstructured":"Habib SS, Eshki A, AlTassan B, Fatani D, Helmi H, AlSaif S. Relationship of serum novel adipokine chemerin levels with body composition, insulin resistance, dyslipidemia and diabesity in Saudi women. Eur Rev Med Pharmacol Sci. 2017;21:1296\u2013302.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"368_CR9","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.2174\/1381612823666170124114524","volume":"23","author":"A Korolczuk","year":"2017","unstructured":"Korolczuk A, Beltowski J. Progranulin, a new adipokine at the crossroads of metabolic syndrome, diabetes, dyslipidemia and hypertension. Curr Pharm Des. 2017;23:1533\u20139.","journal-title":"Curr Pharm Des"},{"key":"368_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/cns.12219","volume":"20","author":"ZY Li","year":"2014","unstructured":"Li ZY, Zheng SL, Wang P, Xu TY, Guan YF, Zhang YJ, et al. Subfatin is a novel adipokine and unlike Meteorin in adipose and brain expression. CNS Neurosci Ther. 2014;20:344\u201354.","journal-title":"CNS Neurosci Ther"},{"key":"368_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.expneurol.2011.09.027","volume":"233","author":"JR Jorgensen","year":"2012","unstructured":"Jorgensen JR, Fransson A, Fjord-Larsen L, Thompson LH, Houchins JP, Andrade N, et al. Cometin is a novel neurotrophic factor that promotes neurite outgrowth and neuroblast migration in vitro and supports survival of spiral ganglion neurons in vivo. Exp Neurol 2012;233:172\u201381.","journal-title":"Exp Neurol"},{"key":"368_CR12","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.cell.2014.03.065","volume":"157","author":"RR Rao","year":"2014","unstructured":"Rao RR, Long JZ, White JP, Svensson KJ, Lou J, Lokurkar I, et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell 2014;157:1279\u201391.","journal-title":"Cell"},{"key":"368_CR13","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.4049\/jimmunol.1800435","volume":"201","author":"I Ushach","year":"2018","unstructured":"Ushach I, Arrevillaga-Boni G, Heller GN, Pone E, Hernandez-Ruiz M, Catalan-Dibene J, et al. Meteorin-like\/meteorin-beta is a novel immunoregulatory cytokine associated with inflammation. J Immunol 2018;201:3669\u201376.","journal-title":"J Immunol"},{"key":"368_CR14","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/aps.2016.9","volume":"37","author":"SL Zheng","year":"2016","unstructured":"Zheng SL, Li ZY, Song J, Liu JM, Miao CY. Metrnl: a secreted protein with new emerging functions. Acta Pharmacol Sin. 2016;37:571\u20139.","journal-title":"Acta Pharmacol Sin"},{"key":"368_CR15","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.2337\/db15-0274","volume":"64","author":"ZY Li","year":"2015","unstructured":"Li ZY, Song J, Zheng SL, Fan MB, Guan YF, Qu Y, et al. Adipocyte metrnl antagonizes insulin resistance through PPARgamma signaling. Diabetes 2015;64:4011\u201322.","journal-title":"Diabetes"},{"key":"368_CR16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1242\/dev.107.4.945","volume":"107","author":"TP Dooley","year":"1989","unstructured":"Dooley TP, Miranda M, Jones NC, DePamphilis ML. Transactivation of the adenovirus EIIa promoter in the absence of adenovirus E1A protein is restricted to mouse oocytes and preimplantation embryos. Development. 1989;107:945\u201356.","journal-title":"Development"},{"key":"368_CR17","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/aps.2016.70","volume":"37","author":"ZY Li","year":"2016","unstructured":"Li ZY, Fan MB, Zhang SL, Qu Y, Zheng SL, Song J, et al. Intestinal Metrnl released into the gut lumen acts as a local regulator for gut antimicrobial peptides. Acta Pharmacol Sin. 2016;37:1458\u201366.","journal-title":"Acta Pharmacol Sin"},{"key":"368_CR18","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/aps.2017.206","volume":"39","author":"JF Wan","year":"2018","unstructured":"Wan JF, Chu SF, Zhou X, Li YT, He WB, Tan F, et al. Ursodeoxycholic acid protects interstitial Cajal-like cells in the gallbladder from undergoing apoptosis by inhibiting TNF-alpha expression. Acta Pharmacol Sin. 2018;39:1493\u2013500.","journal-title":"Acta Pharmacol Sin"},{"key":"368_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1248\/cpb.c17-00846","volume":"66","author":"SL Zheng","year":"2018","unstructured":"Zheng SL, Li ZY, Zhang Z, Wang DS, Xu J, Miao CY. Evaluation of two commercial enzyme-linked immunosorbent assay kits for the detection of human circulating metrnl. Chem Pharm Bull. 2018;66:391\u20138.","journal-title":"Chem Pharm Bull"},{"key":"368_CR20","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41401-018-0195-3","volume":"40","author":"MX Ge","year":"2019","unstructured":"Ge MX, Niu WX, Ren JF, Cai SY, Yu DK, Liu HT, et al. A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters. Acta Pharmacol Sin. 2019;40:895\u2013907.","journal-title":"Acta Pharmacol Sin"},{"key":"368_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep12657","volume":"5","author":"X Wang","year":"2015","unstructured":"Wang X, Xu TY, Liu XZ, Zhang SL, Wang P, Li ZY, et al. Discovery of novel inhibitors and fluorescent probe targeting NAMPT. Sci Rep. 2015;5:12657.","journal-title":"Sci Rep."},{"key":"368_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12848","volume":"7","author":"MB Mobin","year":"2016","unstructured":"Mobin MB, Gerstberger S, Teupser D, Campana B, Charisse K, Heim MH, et al. The RNA-binding protein vigilin regulates VLDL secretion through modulation of Apob mRNA translation. Nat Commun 2016;7:12848.","journal-title":"Nat Commun"},{"key":"368_CR23","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/MOL.0000000000000084","volume":"25","author":"MM Hussain","year":"2014","unstructured":"Hussain MM. Intestinal lipid absorption and lipoprotein formation. Curr Opin Lipido. 2014;25:200\u20136.","journal-title":"Curr Opin Lipido"},{"key":"368_CR24","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1194\/jlr.M300520-JLR200","volume":"45","author":"JD Curb","year":"2004","unstructured":"Curb JD, Abbott RD, Rodriguez BL, Masaki K, Chen R, Sharp DS, et al. A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res. 2004;45:948\u201353.","journal-title":"J Lipid Res"},{"key":"368_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/scientificamerican1184-58","volume":"251","author":"MS Brown","year":"1984","unstructured":"Brown MS, Goldstein JL. How LDL receptors influence cholesterol and atherosclerosis. Sci Am 1984;251:58\u201366.","journal-title":"Sci Am"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-020-0368-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-020-0368-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-020-0368-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:03:00Z","timestamp":1684616580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-0368-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["368"],"URL":"https:\/\/doi.org\/10.1038\/s41401-020-0368-8","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,7]]},"assertion":[{"value":"5 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}